Market Highlights
According to MRFR analysis, the global low-pressure liquid
chromatography market is expected to register a CAGR of ~3.6% from 2020 to
2027.
The global low-pressure liquid chromatography market is
driven by the expansion of research facilities across the globe, increasing
government funding in the healthcare sector, and the rising population
diagnosed with hereditary disorders such as Parkinson's disease, sickle cell
disease, and Alzheimer's disease. In addition, increasing demand for DNA-based,
RNA-based, and protein-based medicines to treat hereditary problems has created
opportunities for the market players. Additionally, the low-pressure liquid
chromatography systems segregate proteins, nucleic acids, and other small &
complex molecules involved in several biological procedures. Moreover, the
low-pressure liquid chromatography is also utilized to separate two polar
organic solutes, screen drugs in sports, and segregate a wide range of
hypersensitive and nonsteroidal anti-inflammatory drugs. The rise in the
adoption of such biological extraction methodologies is expected to augment the
low-pressure
liquid chromatography market.
Get
Sample Report @https://www.marketresearchfuture.com/sample_request/10724
Key Players
Some of the key players in the global low-pressure liquid
chromatography market are Novasep (France), LEWA GmbH (Germany), GALAK
Chromatography Technology Co., Ltd (China), Biolinx Labsystems (India), and
Bio-Rad Laboratories, Inc. (US).
Segmentation
The global low-pressure liquid chromatography market is
segmented into components and end user. Based on component, the market has been
segregated into instruments, consumables, and services. The instruments segment
held a considerable market share in 2020. The demand for low-pressure liquid
chromatography is the largest contributor to the global market due to its high
engagement in research facilities to derive COVID-19 vaccines and other
microbial infection treatments. In addition, the ongoing innovation of drugs
and treatment for chronic diseases are strengthening the demand for
low-pressure liquid chromatography products.
Based on end user, the global low-pressure liquid
chromatography market has been classified as pharmaceutical companies,
biotechnology companies, research laboratories, and academic institutions.
Pharmaceutical companies held a considerable share of the market in 2020, owing
to the high demand for medicines across the globe due to the spread of deadly
coronavirus and chronic diseases. Additionally, increasing public and private
investments in drug development and growing funding in the pharmaceutical
sector to transform the research and production facilities are expected to drive
the segment in the projected timeline.
The industry providers are involved in technological
enhancement, product development, expansion of distribution network, investment
public relations, and mergers & acquisitions to expand their global
footprint. The industry players are planning to adopt business plans such as
the development of advanced low-pressure liquid chromatography systems to
provide accurate and efficient test and extraction results. Additionally, the
global market players aim to invest in the developing countries owing to
supportive government policies, economic labor costs, and the high availability
of raw materials. These factors will strengthen the market development and will
propel the market demand in the projected period.
Regional Analysis
North America is projected to dominate the low-pressure
liquid chromatography market in the forecast period, owing to the presence of a
large number of market players, increasing government fundings, expansion in
research facilities, extensive distribution network, and growing usage of
chromatography in drug development. Furthermore, the key players are involved
in business approaches such as collaborations, mergers, technical partnerships,
government alliances, and an increasing number of clinical trials are a few of
the factors propelling the market growth. Europe embraces the second-largest
position in the low-pressure liquid chromatography market due to the increasing
development, manufacturing, and commercialization of therapeutics, increasing
establishment of analytical and biotechnology laboratories across the region.
Likewise, increasing the utilization of molecular diagnosis for forensic
investigation is driving the European low-pressure liquid chromatography
market. The industry players provide high-quality products and superior
after-sales service to gain an edge over the existing industry providers. These
business parameters are expected to propel the low-pressure liquid
chromatography market in the anticipated time.
Asia-Pacific is likely to hold the major market share over
the assessed timeline due to the transformation in pharmaceutical
infrastructure, high investment in the modernization of research laboratories,
rising demand for generic and advanced medicines across the region, and increasing
awareness about genetic and molecular drugs. Moreover, the rising demand for
environmental and chemical analysis devices and equipment is driving the
Asia-Pacific low-pressure liquid chromatography market.
Furthermore, the development of the market in the Rest of
the World has been gaining market share in the low-pressure liquid
chromatography market over the last few years due to the growing interest of
investors in the local research facilities, supportive government regulations,
establishment of technically advanced pharmaceutical infrastructure and growing
research activities on the extraction of molecular components such as proteins,
RNA, DNA, and other complex molecules. These aspects are likely to fuel the
market growth over the assessed period.
Access full report @ https://www.marketresearchfuture.com/reports/low-pressure-liquid-chromatography-market-10724
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting
Services.
The Wall